Teva Launches Generic Prevacid After Patent Win

Law360, New York (November 10, 2009, 5:59 PM EST) -- Teva Pharmaceutical Industries Ltd. plans to begin marketing a generic version of the acid reflux drug Prevacid now that a federal judge has ruled in its favor in a patent battle with Takeda Pharmaceutical Co. Ltd.

Judge Sue L. Robinson of the U.S. District Court for the District of Delaware issued final judgment for Teva on Tuesday after concluding that Takeda had failed to prove infringement on the final patent-at-issue in the case.

Teva said in a statement that the U.S. Food and Drug Administration has...
To view the full article, register now.